Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
15,948,384
-
Share change
-
+4,476,216
-
Total reported value
-
$180,780,886
-
Put/Call ratio
-
37%
-
Price per share
-
$11.43
-
Number of holders
-
84
-
Value change
-
+$50,990,734
-
Number of buys
-
46
-
Number of sells
-
22
Institutional Holders of ONCOMED PHARMACEUTICALS INC - COM (OMED) as of Q3 2016
As of 30 Sep 2016,
ONCOMED PHARMACEUTICALS INC - COM (OMED) was held by
84 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,948,384 shares.
The largest 10 holders included
ADAMS STREET PARTNERS LLC, BVF INC/IL, PRIMECAP MANAGEMENT CO/CA/, BlackRock Fund Advisors, FRANKLIN RESOURCES INC, FMR LLC, Alyeska Investment Group, L.P., VANGUARD GROUP INC, Iguana Healthcare Management, LLC, and MILLENNIUM MANAGEMENT LLC.
This page lists
84
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.